HKSE - Delayed Quote HKD

China Healthwise Holdings Limited (0348.HK)

0.056 0.000 (0.00%)
At close: 3:48 PM GMT+8
Loading Chart for 0348.HK
DELL
  • Previous Close 0.056
  • Open 0.056
  • Bid 0.052 x --
  • Ask 0.058 x --
  • Day's Range 0.055 - 0.056
  • 52 Week Range 0.034 - 0.142
  • Volume 320,000
  • Avg. Volume 589,874
  • Market Cap (intraday) 43.147M
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.170
  • Earnings Date Mar 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 1, 2005
  • 1y Target Est --

China Healthwise Holdings Limited, an investment holding company, sells Chinese health products in Hong Kong and The People's Republic of China. The company operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. It sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers. The company also sells Chinese health products online. In addition, it provides loans; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited is headquartered in Central, Hong Kong.

www.healthwisehk.com

100

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 0348.HK

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0348.HK
36.59%
HANG SENG INDEX
0.90%

1-Year Return

0348.HK
62.16%
HANG SENG INDEX
14.32%

3-Year Return

0348.HK
83.53%
HANG SENG INDEX
40.85%

5-Year Return

0348.HK
89.43%
HANG SENG INDEX
42.59%

Compare To: 0348.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0348.HK

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    43.15M

  • Enterprise Value

    97.76M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.29

  • Price/Book (mrq)

    9.81

  • Enterprise Value/Revenue

    0.67

  • Enterprise Value/EBITDA

    -0.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -91.96%

  • Return on Assets (ttm)

    -32.18%

  • Return on Equity (ttm)

    -188.13%

  • Revenue (ttm)

    146.32M

  • Net Income Avi to Common (ttm)

    -134.56M

  • Diluted EPS (ttm)

    -0.170

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    59.16M

  • Total Debt/Equity (mrq)

    2,476.13%

  • Levered Free Cash Flow (ttm)

    --

Company Insights: 0348.HK

People Also Watch